Paramit to acquire S.I.E SOLUTIONS to expand into Europe
Paramit, a US-based manufacturer of medical devices and life science instruments, has signed a deal to acquire Austria-based S.I.E. SOLUTIONS, as part of a strategic ... Read More
Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal
German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio ... Read More
AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause
AstraZeneca said that clinical trials for the AZD1222 Covid-19 vaccine candidate, have resumed in various parts of the world after regulators across the US, UK, ... Read More
Covid-19 mRNA vaccine : Precision Nanosystems gets funding boost from Canadian govt
Precision Nanosystems (PNI) has received a funding boost of up to CAD 18.2 million from the Canadian government to develop a mRNA vaccine for Covid-19. ... Read More
Gilead Sciences wraps up $21bn acquisition of Immunomedics
Gilead Sciences has wrapped up its previously announced $21 billion acquisition of New Jersey-based biopharma company Immunomedics. With the completion of the deal, Immunomedics has ... Read More
Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment
Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug ... Read More
VelosBio begins phase 2 trial of VLS-101 in solid tumors
VelosBio, a San Diego-based biopharma company, said that it has dosed the first patient in a phase 2 clinical trial of its investigational antibody-drug conjugate ... Read More
Endo International to acquire BioSpecifics Technologies for $658m
Endo International has agreed to acquire BioSpecifics Technologies, a New York-based commercial-stage biopharma company, for $88.5 per share, or an estimated enterprise value of around ... Read More
Bracco Diagnostics gets FDA nod for CardioGen-82 infusion system
Bracco Diagnostics, the US subsidiary of Italian diagnostic imaging company Bracco Imaging, has secured approval from the US Food and Drug Administration (FDA) for its ... Read More
Lilly to acquire SARM1 inhibitor developer Disarm Therapeutics
Lilly acquisition of Disarm Therapeutics : Eli Lilly and Company (Lilly) has agreed to acquire Disarm Therapeutics, a biotech company based in Cambridge, Massachusetts, which ... Read More